Program Name: 2025 Spring Path to a Cure (PTAC) Research Grant
Brief Program Overview/Description: Path to a Cure: Research Grants are intended to facilitate or enable the development of new information that may contribute to the development of new therapies focused upon repair or replacement of CFTR variants not served by existing small molecule modulators. Proposals must be hypothesis driven and contain sufficient preliminary data to justify support from the Cystic Fibrosis Foundation. However, proposals that aim to develop tools or reagents that are not typically hypothesis driven but may facilitate research that could lead to a cure will be considered through this mechanism. Information derived from such studies will hopefully lead to submission to other funding agencies, such as the National Institutes of Health (NIH).
Applicants seeking to submit proposals focused on topics such as mucociliary clearance and airway hydration, infection and inflammation, or non-lung manifestations of disease should apply through the Research Grant mechanism.
• United States residents and applicants from outside the United States are welcome to apply.
• Applicants must be independent investigators (an individual who is out of fellowship training and whose institution allows them to submit applications for research funding as a Principal Investigator).
o Candidates who are clinical fellows should apply to the CFF Clinical Fellowship program for the appropriate year.
o Candidates who are postdoctoral fellows should apply to the CFF Postdoctoral Research Fellowship program.
• Applicants from for-profit organizations should speak to the Program Officer about eligibility before applying through this mechanism.
• Additional eligibility requirements can be found in Section IV and Section VI (Goals of Research) below.
Sponsor Institute/Organizations: Cystic Fibrosis Foundation
Sponsor Type: Corporate/Non-Profit
Address: 4550 Montgomery Ave. Suite 1100 N Bethesda, MD 20814
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
May 15, 2025
$150,000
Affiliation: Cystic Fibrosis Foundation
Address: 4550 Montgomery Ave. Suite 1100 N Bethesda, MD 20814
Website URL: https://www.cff.org/researchers/path-cure-academic-programs#award-types
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.